Tech Company Financing Transactions
JB Therapeutics Funding Round
On 4/12/2012, JB Therapeutics raised $662 thousand in investment from private investors.
Transaction Overview
Company Name
Announced On
4/12/2012
Transaction Type
Venture Equity
Amount
$662,000
Round
Undisclosed
Investors
Proceeds Purpose
The company plans to use the money to run a Phase 2 clinical trial in the orphan disease systemic sclerosis, a type of scleroderma that affects the skin and vital internal organs such as the lungs, heart, and kidney.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 River Ridge Dr. 103
Norwood, MA 02062
USA
Norwood, MA 02062
USA
Phone
Website
Email Address
Overview
JB Therapeutics, Inc. is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Our lead compound, JBT-101, is a potent CB1 and CB2 agonist with demonstrated efficacy in several animal models of pain and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yuval Cohen
Chief Financial Officer
Sean Moran
Chief Medical Officer
Barbara White
Chief Scientific Officer
Mark Tepper
Browse more venture capital transactions:
Prev: 4/12/2012: Inogen venture capital transaction
Next: 4/12/2012: SoMoLend venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs